User:Mary Mendoza/Notebook/CHEM572 Exp. Biological Chemistry II/2013/02/19: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 16: Line 16:


==Protocol==
==Protocol==
* The portion below was taken from the note book of [[User:Dhea Patel/Notebook/CHEM 572: ADA&Inhibitor Kinetics/2013/02/19 Dhea Patel]].
* The portion below was taken from the note book of [[User:Dhea Patel/Notebook/CHEM 572: ADA&Inhibitor Kinetics/2013/02/19|Dhea Patel]].
* [[Image:Screen_Shot_2013-02-19_at_1.12.45_PM.png]]
* [[Image:Screen_Shot_2013-02-19_at_1.12.45_PM.png]]



Revision as of 08:08, 20 February 2013

Project name <html><img src="/images/9/94/Report.png" border="0" /></html> Main project page
<html><img src="/images/c/c3/Resultset_previous.png" border="0" /></html>Previous entry<html>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</html>Next entry<html><img src="/images/5/5c/Resultset_next.png" border="0" /></html>

ADA Kinetic Assay with Acetylsalicylic Acid inhibitor

  • The objective for this laboratory period was to run ADA Kinetic assay with the addition of the inhibitor.
  • Acetylsalicylic acid (C9H8O4, MW 180.16) was obtained from Sigma-Aldrich, Co.
  • The assay of the acid is ≥ 99.0 %. The solid appeared as a white crystalline form having an absorbance of 230 nm.


  • The first trial conducted did not include the inhibitor for the purpose of obtaining a zero point.
  • There were observed inconsistencies among the 32, 39.7, 141.8, and 200 μM adenosine concentrations. Thus, new concentrations were calculated for adenosine.

Protocol

  • The portion below was taken from the note book of Dhea Patel.

  • The data obtained from the ADA Assay was not consistent with previous findings, so new Adenosine concentrations were made up according to the following table:

Data